History | Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 143 KB)

Published:

06 October 2021
Final appraisal document (updated after appeal period) (PDF 326 KB)

Published:

06 October 2021
Register of interests (PDF 158 KB)

Published:

06 October 2021

Final draft guidance

Final draft guidance
Final appraisal document (PDF 307 KB)

Published:

01 September 2021
Committee papers (PDF 9.94 MB)

Published:

01 September 2021
Public committee slides (PDF 1.34 MB)

Published:

01 September 2021

Invitation to participate

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 115 KB)

Published:

26 August 2020
Final scope (PDF 90 KB)

Published:

26 August 2020
Final stakeholder list (PDF 171 KB)

Published:

26 August 2020
Equality impact assessment (Scoping) (PDF 125 KB)

Published:

26 August 2020

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 211 KB)

Published:

13 July 2020
Draft matrix post referral (PDF 170 KB)

Published:

13 July 2020